System for blood preservation and biobanking
On May 2019 Spark-Tech signed a grant agreement with The National Centre for Research and Development to develop Spark-Tech Biobanking System (STBS). The value of the project amounts 2,6 mln € (11 300 248,31 PLN) with the EU contribution of 2,2 mln € (8 836 058,10 PLN). The project will be conducted from June 2019 to May 2022.
Spark-Tube Biobanking System (STBS) was invented to make current complex methods of blood preservation and biobanking more efficient, robust and simplified. The need for such system unfolded when conducting research projects aimed at identification and validation of disease biomarkers in blood. There were two major limitations in the state-of-the-art blood-based biomarker diagnostics: lack of technical solution allowing fully automated, high-throughput blood preservation combined with laborious and very expensive manual procedures.
Spark-Tech is constantly looking for talents. Consider joining our project team!
Given the limitations in currently available methods, STBS thanks to its novel technology (separation of blood-fractions, long-term preservation and banking) is expected to overcome the roadblocks in accessing blood preservation solutions and become universal biobanking platform. The system will find wide application in medical diagnostics (including genetic biobanks), clinical drug trials, and clinical research. STBS is not only a high impact medical ‘tool’ but also a great business opportunity as it can be utilized in many different economical environments where cost effective solutions are necessary to change the social limitations of clinical blood processing.
Spark-Tech is conducting a project entitled: “Spark-Tube Biobanking System (STBS)’’ co-financed by The National Centre for Research and Development. Companies interested in participating in the project are invited to contact us or to submit offers by responding to one of our public tenders.